Dublin, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The "Extracellular Vesicles & Nanoparticle-based Therapeutics Europe 2023" conference has been added to ResearchAndMarkets.com's offering.
This premier event serves as a groundbreaking convergence of Exosomes-EV Research, Nanoparticles, and the vast Therapeutic Opportunities that await in this transformative landscape, circa 2023.
Over the course of two days, this conference will gather prominent key opinion leaders and thought leaders from Europe and around the globe, providing an unrivaled platform for scientific presentations, networking, and meaningful engagement with pioneering companies at the forefront of tools and technologies in this rapidly expanding field.
Distinguished by its exceptional lineup, the conference proudly brings together a diverse speaking faculty comprising esteemed academic thought leaders and leading industry participants, both actively translating cutting-edge technologies into commercial offerings and driving unprecedented innovations in this dynamic arena.
This conference features scientific presentations, industry technology spotlight presentations, posters as well as a co-located exhibition, and the conference features companies in this field developing technologies, products and services as well as moving (clinical) candidates forward into the clinical trials regimen.
The conference features extensive networking opportunities and is held 7-minutes walk from Rotterdam Centraal with fast and very easy access to Amsterdam-Schiphol with worldwide connections as well as the Eurostar to London plus fast-trains to Antwerp, Brussels and Paris.
The Conference is Chaired by Leaders in the Field:
- Professor Dr. Raymond Schiffelers, Professor of Nanomedicine, University Medical Center Utrecht
- Professor Dr. Dominique PV de Kleijn, Professor Experimental Vascular Surgery; Professor Netherlands Heart Institute, University Medical Center Utrecht
Agenda:
- Animal Models for Studying Extracellular Vesicles for Therapeutics, Drug Delivery
- Engineered EVs and Engineered Nanoparticles - Features, Benefits and Therapeutic Applications
- Expression and Deployment of Biologics from Extracellular Vesicles (EV) for Therapeutics Applications
- Extracellular Vesicles (EVs): Therapeutic and Drug Delivery Potential
- Extracellular Vesicles and MSCs
- An Emerging Area of Investigation for Regenerative Medicine
- Nanoparticles as Delivery Vehicles
- Biologics -Engineered Nanoparticles for Drug Delivery
- Vaccines - Technologies for Engineering EVs for Therapeutics, Drug Delivery Vehicles, Biologics
Speakers
Conference Chairs
- Raymond Schiffelers - Professor of Nanomedicine, University Medical Center Utrecht
- Dominique PV de Kleijn - Professor Experimental Vascular Surgery; Professor Netherlands Heart Institute, University Medical Center Utrecht
Keynote Speakers
- Mario Gimona - Head of Manufacturing, GMP Unit, Paracelsus Medical University Salzburg
- Alain Brisson - Professor Emeritus, University of Bordeaux
- Eva Rohde - Head of Department for Transfusion Medicine, Director of GMP Laboratory, Paracelsus Medical University Salzburg
- Sai Kiang Lim - Research Director, Institute of Medical Biology, A*STAR
- Bernd Giebel - Group Leader, Institute for Transfusion Medicine, University Hospital Duisburg-Essen
- Samir EL-Andaloussi - Associate Professor, Karolinska Institutet
For more information about this conference visit https://www.researchandmarkets.com/r/7h6iu0
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
